Interestingly, higher expression of RNF2 induces cisplatin resistance in ovarian cancers, and its knockdown enhanced the radiosensitivity of lung cancer cell lines, suggesting its role in promoting tumorigenesis (46, 47). Here, RNF2 is linked to lung carcinoma.